Perbedaan Saraswanti Indoland Development Tbk. dan Tempo Scan Pacific Tbk.: Saraswanti Indoland Development Tbk. diperdagangkan di Rp92 (kapitalisasi pasar 490,04 M, volume 24 jam 1,51 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.580 (kapitalisasi pasar 11,68 T, volume 24 jam 429,7 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 23,8× kapitalisasi pasar Saraswanti Indoland Development Tbk., dan Saraswanti Indoland Development Tbk. lebih aktif diperdagangkan (1,51 jt vs 429,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| SWID | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 490,04 M | 11,68 T |
Volume | 1,51 jt | 429,7 rb |
Lot | 15,14 rb | 4,3 rb |
Perputaran | 137,63 jt | 1,11 M |
Harga Rata-rata | 90,94 | 2.591,65 |
Nilai Transaksi | 137,63 jt | 1,11 M |
Harga Ekuilibrium Indikatif | 92 | 2.580 |
Volume Ekuilibrium Indikatif | 1,49 rb | 100 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Selengkapnya di halaman SWID →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →